PHATHOM PHARMACEUTICALS, INC. (PHAT)

9.18 +2.68% (+0.24)

Over 6M: -19.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

8 10 12
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -29.1M Q3 '21 — Free Cash Flow: -29.1M Q3 '21 — Net Income: -36.7M Q4 '21 — Operating Cash Flow: -41.3M Q4 '21 — Free Cash Flow: -41.4M Q4 '21 — Net Income: -35.8M Q1 '22 — Operating Cash Flow: -44.8M Q1 '22 — Free Cash Flow: -44.8M Q1 '22 — Net Income: -40.7M Q2 '22 — Operating Cash Flow: -25.7M Q2 '22 — Free Cash Flow: -26.1M Q2 '22 — Net Income: -50.9M Q3 '22 — Operating Cash Flow: -35M Q3 '22 — Free Cash Flow: -35.1M Q3 '22 — Net Income: -51.1M Q4 '22 — Operating Cash Flow: -41M Q4 '22 — Free Cash Flow: -41.5M Q4 '22 — Net Income: -55M Q1 '23 — Revenue: 0 Q1 '23 — Operating Cash Flow: -39.7M Q1 '23 — Free Cash Flow: -39.9M Q1 '23 — Net Income: -37.8M Q2 '23 — Revenue: 0 Q2 '23 — Operating Cash Flow: -22.2M Q2 '23 — Free Cash Flow: -22.2M Q2 '23 — Net Income: -41M Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -31.9M Q3 '23 — Free Cash Flow: -32.9M Q3 '23 — Net Income: -43.2M Q4 '23 — Revenue: 682K Q4 '23 — Operating Cash Flow: -43.8M Q4 '23 — Free Cash Flow: -44.3M Q4 '23 — Net Income: -79.6M Q1 '24 — Revenue: 1.9M Q1 '24 — Operating Cash Flow: -69M Q1 '24 — Free Cash Flow: -69.1M Q1 '24 — Net Income: -82.9M Q2 '24 — Revenue: 7.3M Q2 '24 — Operating Cash Flow: -70.7M Q2 '24 — Free Cash Flow: -70.8M Q2 '24 — Net Income: -91.4M Q3 '24 — Revenue: 16.4M Q3 '24 — Operating Cash Flow: -63.6M Q3 '24 — Free Cash Flow: -63.6M Q3 '24 — Net Income: -85.6M Q4 '24 — Revenue: 29.7M Q4 '24 — Operating Cash Flow: -63.5M Q4 '24 — Free Cash Flow: -63.5M Q4 '24 — Net Income: -74.5M Q1 '25 — Revenue: 28.5M Q1 '25 — Operating Cash Flow: -84.9M Q1 '25 — Free Cash Flow: -84.9M Q1 '25 — Net Income: -94.3M Q2 '25 — Revenue: 39.5M Q2 '25 — Operating Cash Flow: -62.7M Q2 '25 — Free Cash Flow: -62.8M Q2 '25 — Net Income: -75.8M Q3 '25 — Revenue: 49.5M Q3 '25 — Operating Cash Flow: -14.1M Q3 '25 — Free Cash Flow: -14.1M Q3 '25 — Net Income: -30M Q4 '25 — Revenue: 57.6M Q4 '25 — Operating Cash Flow: -5M Q4 '25 — Free Cash Flow: -5.1M Q4 '25 — Net Income: -21.1M Q1 '26 — Revenue: 58.3M Q1 '26 — Operating Cash Flow: -15.6M Q1 '26 — Free Cash Flow: -15.7M Q1 '26 — Net Income: -30.4M Q2 '26 — Revenue: 74.3M Q2 '26 — Operating Cash Flow: -1.9M Q2 '26 — Free Cash Flow: -2M Q2 '26 — Net Income: -17.6M -70M -35M 0 35M 70M 105M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.0
SBC / sales 11.3%
OE margin -26.7%
Oper. margin -17.0%
Accruals -19.1%
Capex / sales 0.091%
Gross margin 82.9%
EBITDA margin -16.7%
FCF margin -15.4%
OCF margin -15.3%
Profit margin -41.3%
ROA -30.3%
ROCE -23.5%
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.4
RPO / sales 0.16×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.8
ND/EBITDA —
Interest cover -0.64×
Debt payback 0.0 yr
Quick ratio 1.9×
Cash / Debt 1.1×
Cash runway 0.48 yr
F-score 4.0 pts
Debt / Eq —
Equity / Assets —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales/sh Y/Y +82.1%
Sales Q/Q +88.0%
Shares change +15.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.